Journal Scans
Bisphosphonate Use After Estrogen Receptor-Positive Breast Cancer and Risk of Contralateral Breast Cancer
Bisphosphonates Reduce Risk of Contralateral Breast Cancer
GM Monsees, KE Malone, M-T Tang, PA Newcomb, CI Li
20111107
2011 Dec 7
J Natl Cancer Inst
Bisphosphonate Use After Estrogen Receptor-Positive Breast Cancer and Risk of Contralateral Breast Cancer
J Natl Cancer Inst. 2011 Dec 7;103(23):1752-1760, GM Monsees, KE Malone, M-T Tang, PA Newcomb, CI Li
TAKE-HOME MESSAGE
Abstract
SUMMARY
OncologySTAT Editorial Team
For patients who survive breast cancer, current strategies for preventing a second primary breast cancer in the contralateral breast include adjuvant hormonal therapy and prophylactic contralateral mastectomy. A possible alternative approach is the use of bisphosphonates, which have shown promise in preventing primary breast cancer. Monsees et al, from the Fred Hutchinson Cancer Research Center, Seattle, report the first detailed population-based study to examine the association between bisphosphonate...